Zacks Investment Research, Inc. resumes coverage f
Post# of 30028
(Total Views: 568)
Posted On: 07/21/2017 1:31:16 PM
Zacks Investment Research, Inc. resumes coverage for AMARANTUS BIOSCIEN COM USD0.001 with BUY recommendation.
BY Investars Analyst Actions - private
— 12:17 PM ET 07/21/2017
On July 21, 2017 Zacks Investment Research, Inc. resumed coverage for AMARANTUS BIOSCIEN COM USD0.001 with a BUY recommendation.
Look, I'm as ADHD as the next guy, but this is kinda ridiculous...
BY Investars Analyst Actions - private
— 12:17 PM ET 07/21/2017
On July 21, 2017 Zacks Investment Research, Inc. resumed coverage for AMARANTUS BIOSCIEN COM USD0.001 with a BUY recommendation.
Look, I'm as ADHD as the next guy, but this is kinda ridiculous...
(1)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼